Company intelligence / Profile preview
Guangxi Nanning Baihui Pharmaceutical
Nanning, Guangxi Zhuang Autonomous Region, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Over 244 registered pharmaceutical products including formulations and APIs, many are on national essential drug lists and regional healthcare/product reimbursement lists. Marketed drugs include glucose injection, inosine oral solution, propylthiouracil (for Graves’ disease); core medicines well established in China and at least one approval in Canada (historically).
- Therapeutic areas
- ImmunologyEndocrinologyGastroenterologyPulmonologyCardiovascularOther
- Modalities
- Small moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on Guangxi Nanning Baihui Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangxi Nanning Baihui Pharmaceutical.